News

October 21, 2019October 21, 2019

Pediatric-onset IBD Patients Experience More Severe Disease Than Those Diagnosed as Adults, Population-Based Study Says

News

Patients whose symptoms of inflammatory bowel disease (IBD) first appeared during their childhood usually experience more severe disease compared with those whose symptoms started later in adulthood, a study ... Read more

October 18, 2019October 18, 2019

Gali Health Introduces Intelligent Personal Assistant for IBD Patients

News

To help people with inflammatory bowel disease (IBD) manage the complex and unpredictable disorder, Gali Health has introduced an artificial intelligence (AI)-powered personal health assistant. The free application for ... Read more

October 16, 2019October 16, 2019

Caregivers of People Living with IBD Need Better Support, National Survey Finds

News

Results from a national survey highlight the heavy burden inflammatory bowel disease (IBD) places on patients’ family and friends, and the need for new strategies to provide better support ... Read more

October 14, 2019October 14, 2019

Prometheus and Takeda Collaborate on Development of Targeted IBD Therapies

News

Biopharmaceutical company Prometheus Biosciences is collaborating with pharmaceutical firm Takeda to discover, develop, and commercialize a new generation of targeted therapies for inflammatory bowel disease (IBD). The global, multi-target ... Read more

October 9, 2019October 9, 2019

Interim Analysis Suggests Wider-than-expected Dosing Range for IMU-838 to Treat Ulcerative Colitis

News

Interim analysis of a Phase 2 clinical trial that’s investigating IMU-838 in people with ulcerative colitis (UC) suggests a broader dose range than initially anticipated, announced the therapy’s developer, ... Read more

October 7, 2019October 7, 2019

Diet Low in Fermented Sugars May Ease IBD Symptoms, Study Reports

News

A diet that is low in fermented sugars may help alleviate symptoms of inflammatory bowel disease (IBD), a study suggests. The study, “Effects of Low-FODMAP Diet on Symptoms, Fecal ... Read more

October 4, 2019October 4, 2019

2 Microbiome-Based Potential Therapies for IBD Enter Early Testing, Biomica Announces

News

Biomica announced the start of preclinical studies to test the anti-inflammatory abilities of two of its microbiome-based therapies for inflammatory bowel disease (IBD). The company’s potential microbe treatments aim to ... Read more

October 2, 2019October 2, 2019

Entyvio Seen as Superior to Humira in Treating Active UC, Phase 3 Trial Shows

News

One year of treatment with Entyvio (vedolizumab) was found to be superior to Humira (adalimumab) in achieving disease remission in people with ulcerative colitis (UC), a common form of inflammatory bowel disease ... Read more

September 30, 2019September 30, 2019

Galapagos NV Launching Phase 1 Trial for Dual Action Anti-inflammatory Molecule

News

Galapagos NV‘s potential new therapy for inflammatory bowel disease (IBD) — which stimulates anti-inflammatory signals while inhibiting pro-inflammatory ones — will move into Phase 1 clinical testing, the company ... Read more

September 27, 2019September 27, 2019

Innate Biologics Granted Patent for Modified Anti-inflammatory Bacterial Proteins

News

Innate Biologics has been granted a U.S. patent for its bacterial protein-based anti-inflammatory technology, the company announced in a press release. The technology is based off of bacterial E3 ... Read more